Nobivac for Feline 1-HCP + FeLV (25 Doses) - [Vaccine]

Nobivac Feline 1-HCP + FeLV is a combination vaccine for cats, formulated to provide essential protection against core feline viruses and feline leukemia virus (FeLV). This comprehensive vaccine is recommended for healthy cats 9 weeks of age or older to help prevent respiratory and gastrointestinal illnesses, as well as diseases associated with FeLV infection and lymphoid tumors.

Feline Vaccine Protection Includes:

• Feline Rhinotracheitis (FVR)
• Feline Calicivirus (FCV)
• Feline Panleukopenia Virus (FPV)
• Feline Leukemia Virus (FeLV) – subgroups A and B

Key Features & Benefits

• Provides core protection with extended 2-year immunity against feline leukemia virus
• Only USDA-licensed FeLV vaccine with a 2-year duration of immunity (DOI)^1,5,8
• Prevents persistent viremia following exposure to virulent FeLV
• Demonstrated superior efficacy compared to multiple FeLV vaccines^6–7
• Blocks replication of canine parvovirus (CPV) in cats¹
• Safe for indoor and outdoor cats of all ages — ideal for kittens under 1 year old
• Proven safety profile: 99% reaction-free in millions of administered doses¹
• Non-adjuvanted formula for reduced risk of adverse reactions

Indications

• Approved for use in healthy cats as an aid in preventing disease caused by FHV-1 (rhinotracheitis), FCV (calicivirus), FPV (panleukopenia), and FeLV
• Helps prevent FeLV-related lymphoid tumors and systemic disease
• Recommended for healthy cats 9 weeks of age or older
• Essential for multi-cat households, outdoor cats, or cats exposed to unknown feline populations

Recommended Vaccination Schedule for Nobivac Feline 1-HCP + FeLV

• For cats 9 weeks of age or older
• Administer a 1 mL dose via subcutaneous or intramuscular injection
• Repeat with a second 1 mL dose 3 to 4 weeks later
• Revaccination every 2 years with Nobivac Feline 1-HCP + FeLV is recommended
• In intervening years, annual revaccination with Nobivac Feline 1-HCP is advised

Safety Information

• 98.8% reaction-free in controlled field safety studies
• 99.99% reaction-free in ongoing surveillance across millions of doses¹
• No signs of inflammation or adjuvant detected 21 days post-subcutaneous administration¹
• Two-year duration of immunity (DOI) reduces frequency of vaccinations

Precautions

• Store at 2°–7°C (36°–45°F)
• Do not freeze
• Do not mix with other vaccines
• Use only new, non-chemically sterilized needles and syringes
• Burn vaccine container and any unused contents after administration

Warnings

• Contains gentamicin and amphotericin B as preservatives
• Vaccinate only healthy, non-parasitized cats
• Do not vaccinate pregnant cats
• As with any biological product, anaphylaxis or other hypersensitivity reactions may occur. Recommended treatment: Epinephrine, corticosteroids, and/or antihistamines as indicated by severity
• The timing of maternal antibody interference with vaccine efficacy varies by the cat's maternal antibody level and absorption of colostrum